Comparison of the efficacy of first-line therapy with different generations of EGFR tyrosine kinase inhibitors in patients with advanced EGFR-associated non-small cell lung cancer: a network meta-analysis of overall survival data

Современная онкология

Mikhail Y. Fedyanin¹  Alexey A. Bogdanov²  Fedor V. Moiseenko²  Vitalii V. Egorenkov²  Nikita M. Volkov²  Andrey A. Bogdanov² 

[1] Blokhin National Medical Research Center of Oncology;Saint Petersburg Clinical Research and Practice Centre for Specialized Types of Medical Care (Oncological);

关键词: non-small-cell lung carcinoma;    egfr;    tyrosine kinase inhibitors;    overall survival;   

DOI  :  10.26442/18151434.2021.1.200731

来源: DOAJ

【 授权许可】

Unknown